732 Followers on Owler
Fate is a California-based company that develops programmed cellular immunotherapies for treating metastatic cancer, traumatic injury, and degenerative diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
Fate is a California-based company that develops programmed cellular immunotherapies for treating metastatic cancer, traumatic injury, and degenerative diseases... Read more
Fate Therapeutics President & CEO: Bahram Valamehr

President & CEO

Bahram Valamehr

CEO Approval Rating

82/100

2007

PublicNASDAQFATE

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$8.5M
Employees
550
Funding
$366.3M
Acquisitions
1

News

Leadership Change
Oct 14, 2025
GlobalNewswire
Kamal Adawi joined Fate Therapeutics as Chief Financial Officer

Fate Therapeutics Competitors

1Kadmon
2Juno Therapeutics
3Chimerix
4G1 Therapeutics
5bluebird bio
6Priothera
7Atox Bio
8BioCryst
9Novartis
10Pfizer
Unlock 7 + competitors

Trending Companies